HOME >> BIOLOGY >> NEWS
Spotlight on liver disease: Improving today's treatments

WASHINGTON, D.C. (May 20, 2007) Patients with liver disease often suffer from other related illnesses, including type-2 diabetes, obesity and high blood pressure, among others. Research presented today at Digestive Disease Week 2007 (DDW) explores the many unknowns of liver disease by examining new liver biomarkers, understanding disease complications and assessing novel treatments for their disease-fighting potential. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

"There is still so much that researchers need to understand about the liver and its related diseases," said Jacquelyn J. Maher, M.D., University of California, San Francisco. "Studies like these help us recognize important connections between the liver and other organs and highlight creative approaches to liver disease treatment that promise to improve the outcome of the most seriously ill patients."

Prediction of Coronary Atherosclerosis Disease with Liver Transaminases Level (Abstract #T1082)

Recent studies have shown that non-alcoholic fatty liver disease (NAFLD) is associated with a condition known as the metabolic syndrome, which includes central obesity, type-2 diabetes, dyslipidemia and high blood pressure. However, the direct influence of NAFLD on coronary atherosclerotic disease (CAD, plaque build up in arteries) has not been investigated. This study, conducted by researchers at Isfahan University of Medical Sciences and Health Services in Isfahan, Iran, evaluated the predictive value of liver biomarkers for coronary atherosclerosis in patients with coronary heart disease (CHD).

The study enrolled 630 patients with suspicious CAD who were candidates for a coronary angiography. To assess the predictive risk of CAD, all study participants were measured for serum AST (aspartate transaminase) and ALT (alanine transaminase) concentrat
'"/>

Contact: Aimee Frank
AFrank@gastro.org
301-941-2620
American Gastroenterological Association
20-May-2007


Page: 1 2 3

Related biology news :

1. Smokeless tobacco more effective than cigarettes for delivering dangerous carcinogens into the body
2. OHSU turns mouse into factory for human liver cells
3. New test improves detection of liver cancer
4. Molecule blocks gene, sheds light on liver cancer
5. Under magnetic force, nanoparticles may deliver gene therapy
6. Discoverer of Sly Syndrome finds way of delivering medicine to fight rare genetic disorder
7. Monell researchers find metabolic defect in liver that can lead to obesity
8. Antibody retards growth and induces death in liver cancer cells
9. Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
10. Nexavar significantly extends overall survival by 44 percent in liver cancer patients
11. New treatment increases life time expectancy of patients suffering from advanced liver cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, ... need a comparability study, but what is the most effective way to complete ...
(Date:7/2/2020)... ... July 02, 2020 , ... Dutch ... the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for SARS-CoV-2 ... The article, titled "Ultra-fast one-step RT-PCR protocol for the detection of SARS-CoV-2," ...
(Date:6/28/2020)... JUPITER, Fla. (PRWEB) , ... June 25, 2020 , ... ... will focus on innovations in accelerated Point of Care Testing solutions (POCT). Check local ... labs. Samples are collected at medical offices and are shipped to labs throughout the ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... After research ... The completion of a great surgery is only the beginning of a successful study, ... research community. , Join Brad Gien, Global Head of Surgery from Envigo ...
(Date:7/18/2020)... ... 16, 2020 , ... Medial EarlySign , a leader ... of high-burden diseases, and Centric Consulting, a business and technology consulting firm, today ... data in order to identify and prioritize patients for care. , Combining Centric’s ...
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research using ... suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. ... has been using the zebrafish model to investigate the causes of leukaemia and ...
Breaking Biology Technology:
Cached News: